Publications found:
51,015
Sort by:
Diagnostic Testing in the US: Market Segment Forecasts and Supplier Shares
US$ 4,320.00
This new report from Venture Planning Group provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer ...
May 2013
101 pages
US Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers
US$ 7,760.00
... shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ...
May 2013
620 pages
US Shale Gas Hydraulic Fracturing Industry 2013-2018: Trend, Profit, and Forecast Analysis, May 2013
US$ 2,650.00
... US shale gas hydraulic fracturing industry. The industry needs to focus more on the environmental impacts of shale gas hydraulic fracturing for further growth to occur in the industry. Environment-friendly hydraulic fracturing fluid ... provides an overview of the US shale gas hydraulic fracturing industry. This report includes the use of hydraulic fracturing for the extraction of unconventional shale gas in the United States only. The report provides ...
May 2013
61 pages
Analysis of Coronary Stent in US
US$ 1,200.00
... , and a severe rise in chronic diseases. According to our report “Analysis of Coronary Stent in US”, reducing the burden of chronic diseases will have a significant ... . The report also provides the existing and future market dynamics of the coronary stent market in US. Further, the report provides a detailed ...
May 2013
45 pages
2013 Analysis of the US Infectious Disease Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 7,880.00
This report presents a comprehensive analysis of the US infectious disease testing market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current ...
April 2013
1037 pages
2013 Analysis of the US Molecular Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 7,600.00
This report presents a comprehensive analysis of the US molecular diagnostics market, including: Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten ...
April 2013
880 pages
2013 Analysis of the US Microbiology Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 7,840.00
Complete report $9,400. DataPack (test volumes, sales forecasts, supplier shares) $3,450. Highlights Comprehensive 1,037-page analysis of the US microbiology testing market. Major issues pertaining to the US microbiology laboratory practice, as well as key economic, regulatory, demographic, social and ...
April 2013
1037 pages
2013 Analysis of the US Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 7,760.00
Complete report $8,700. DataPack (test volumes, sales forecasts, supplier shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
April 2013
620 pages
2013 Analysis of the US Blood Banking Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 7,760.00
This report presents a comprehensive analysis of the US blood banking market, including: Major issues pertaining to the US blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Specifically, the ...
April 2013
460 pages
2013 Analysis of the US Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 7,840.00
This report presents a comprehensive analysis of the US cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2013
620 pages
2013 Analysis of the US Clinical Chemistry and Immunodiagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 9,200.00
This report presents a comprehensive analysis of the US clinical chemistry and immunodiagnostics markets, including: Major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with ...
April 2013
600 pages
2013 Analysis of the US Coagulation Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 7,680.00
This report presents a comprehensive analysis of the US coagulation market, including: Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year ...
April 2013
424 pages
2013 Analysis of the US Flow Cytometry Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 5,360.00
Complete report $5,900. DataPack (test volumes, sales forecasts, supplier shares) $2,350. This report presents a comprehensive analysis of the US flow cytometry market, including: Major issues pertaining to the US flow cytometry practice, as well as key economic, regulatory, demographic, social and ...
April 2013
174 pages
2013 Analysis of the US Hematology and Flow Cytometry Markets: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 7,880.00
Complete report $9,500. DataPack (test volumes, sales forecasts, supplier shares) $3,800. This report presents a comprehensive analysis of the US hematology and flow cytometry markets, including: Major issues pertaining to the US hematology and flow cytometry practice, as well as key economic, regulatory, ...
April 2013
275 pages
ENDOCYTE - Small and Powerful Targeted Therapy!
US$ 140.00
Endocyte’s (ECYT) SMDC technology platform and drug pipeline caught investor’s ... our initiation report released on 19th April, 2013 on ECYT titled “Small and Powerful Targeted Therapy!
April 2013
11 pages
Animal Food - United States
US$ 653.00
... on the actual market situation, trends and future outlook for animal food in United States. The study provides essential market information for decision- ... market study answers to questions such as: What is the size of the animal food market in United States? How is the market divided into different types of ...
April 2013
20 pages
Pasta - United States
US$ 653.00
... on the actual market situation, trends and future outlook for pasta in United States. The study provides essential market information for decision-makers ... This market study answers to questions such as: What is the size of the pasta market in United States? How is the market divided into different types of ...
April 2013
21 pages
Sugar - United States
US$ 653.00
... on the actual market situation, trends and future outlook for sugar in United States. The study provides essential market information for decision-makers ... This market study answers to questions such as: What is the size of the sugar market in United States? How is the market divided into different types of ...
April 2013
24 pages
Confectionery Product Market in United States
US$ 653.00
... for confectionery products by type Forecasts and future outlook of the market Macroeconomic indicators This market study answers to questions such as: What is the size of the confectionery product market in United States? How is the market divided into different types of products? ...
April 2013
23 pages
ENANTA PHARMA - Debut of a Star- 2nd in the Oral IFN free HCV Drug Race!
US$ 140.00
... acquisition of Pharmasset in 2011 and ABBV through its alliance with Enanta (ENTA) in 2006. Gilead’s Sofosbuvir (PhIII, PMI) in combination with RBV ... our initiation report released on 17th April, 2013 on ENTA titled “Debut of a Star- 2nd in the Oral IFN free HCV Drug Race ...
April 2013
8 pages
2013 U.S. Radio, Television & Electronics Stores Industry-Industry & Market Report
US$ 149.00
The U.S. Radio, Television & Electronics Stores Industry-Industry & Market Report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2013 current and 2014 forecast estimates on the size of the industry (sales, establishments ...
April 2013
223 pages
VERTEX PHARMA - Dependence on Success of its CF Pipeline = Risk
US$ 140.00
Vertex Pharma’s (VRTX) stock has moved up ~30% in this year mostly based on the ... detail, please read our report released on 9th March, 2013 on Vertex titled “Dependence on Success of its CF Pipeline = Risk!” Companies mentioned Vertex Pharma
April 2013
4 pages
RIGEL - SyK Inhibition Not Good Enough - Limited Market Potential!
US$ 140.00
RIGL/AZN’s Fostamatinib (FosD, syk inhibitor, PhIII) has again disappointed by not demonstrating better or at par efficacy with approved or competing RA drugs. ... , please read our report released on April 5, 2013, titled, “SyK Inhibition Not Good Enough - Limited Market Potential!” Companies mentioned Rigel
April 2013
5 pages
BIOGEN IDEC - Hold On - After TECFIDERA Array of Approvals Yet to Come!
US$ 140.00
... -release capsule of dimethyl fumerate) with a ‘clean’ label should seal Biogen Idec (BIIB)’s supremacy in the MS space. We expect TECFIDERA to become the ... our report released on 28th March, 2013 on BIIB titled, “Hold On - After TECFIDERA Array of Approvals Yet to Come!” Companies mentioned BIIB, BIOGEN IDEC
March 2013
6 pages
TRIUS THERAPEUTICS - Partnering or Buy Out = Upside
US$ 90.00
... and Skin Structure Infections – ABSSSI; PhII, CAP/HAP/Bacteremia, partnered with Bayer for Asian, LA and ME rights) from 2nd pivotal ... , please read our initiation report released on 26th March, 2013 on Trius (TSRX) titled “Partnering or Buy Out = Upside” Companies mentioned Trius Therapeutics
March 2013
4 pages
US Blood Banking Market Outlook: Innovations, Trends and Opportunities for Suppliers
US$ 7,760.00
This report presents a comprehensive analysis of the US blood banking market, including: Major issues pertaining to the US blood banking practice, as well as key economic, ... other key issues. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT ...
March 2013
460 pages
US Coagulation Market Outlook: Innovations, Trends and Opportunities for Suppliers
US$ 7,680.00
This report presents a comprehensive analysis of the US coagulation market, including: Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year ...
March 2013
424 pages
Cement - United States
US$ 653.00
... on the actual market situation, trends and future outlook for cement in United States. The study provides essential market information for decision-makers ... This market study answers to questions such as: What is the size of the cement market in United States? How is the market divided into different types of ...
March 2013
21 pages
Competing in the US Cancer Diagnostics Market
US$ 7,840.00
... trends with significant market impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Five- ...
February 2013
620 pages
Competing in the US Clinical Chemistry and Immunodiagnostic Markets
US$ 9,200.00
... . Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
February 2013
600 pages
Competing in the US Coagulation Market
US$ 7,680.00
... and technological trends with significant market impact during the next five years. Five-year volume and sales forecasts for 40 coagulation procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads. Placement estimates for major ...
February 2013
424 pages
Competing in the US Hematology and Flow Cytometry Markets
US$ 7,880.00
This new 275-page report from Venture Planning Group contains 42 tables, and presents a comprehensive analysis of the US hematology and flow cytometry markets, including: Major issues pertaining to the US hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and ...
February 2013
275 pages
Competing in the US Infectious Disease Testing Market
US$ 7,880.00
This new 1,037-page report from Venture Planning Group contains 177 tables, and presents a comprehensive analysis of the US infectious disease testing market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends ...
February 2013
1037 pages
Competing in the US Molecular Diagnostics Market
US$ 7,600.00
... . Feature comparison of automated and semiautomated analyzers. Sales and market shares of leading suppliers. Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, ...
February 2013
880 pages
ACORDA - Building Confidence Beyond AMPYRA!
US$ 140.00
Acorda Therapeutics (ACOR) reported 4Q/FY12 results with a decent growth in sales ... label expansion of AMPYRA (POC data in 2Q13) and pipeline beyond AMPYRA could lead to the next driver to the stock. Successful ... our report released on 15th February 2013 on ACOR titled “Building Confidence Beyond AMPYRA!”
February 2013
3 pages
INFINITY - IPI-145, Unpartnered, Potent PI3K Inhibitor = Larger Opportunity!
US$ 140.00
... both hematologic malignancies and inflammation indication has sparked interest in Infinity Pharma (INFI). Despite limited clinical data in hand, PC and in vitro ... read our report released on 13th February 2013 on INFI titled “IPI-145, Unpartnered, Potent PI3K Inhibitor = Larger Opportunity!”
February 2013
8 pages
